Lioy et al, Thiol suppression of human immunodeficiency virus type 1 replication in primary cord blood monocyte-derived macrophages in vitro, J. Clin. Invest., 91(2); 495-498, 1993.* |
Barnett and Fulton, 1971, “Differential Response of Prunus Necrotic Ringspot and Tulare Apple Mosaic Viruses to Stabilizing Agents,” Virology 46(3):613-619. |
Kameoka et al., 1996, “Intracellular glutathione as a possible direct blocker of HIV type 1 reverse transcription,” AIDS Res. Hum. Retroviruses, 12(17):1635-1638. |
Lioy et al., 1993, “Thiol suppression of human immunodeficiency virus type 1 replication in primary cord blood monocyte-derived macrophages in vitro,” J. Clin. Invest. 91(2):495-498. |
McDonnell et al., 1997, “Zinc ejection as a new rationale for the use of cystamine and related disulfide-containing antiviral agents in the treatment of AIDS,” J. Med. Chem. 40(13):1969-1976. |
Murata and Kitagawa, 1973, “Mechanism of inactivaiton of bacteriophase J1 by dithiothreitol, cysteine, mercaptoethanol, or thioglycollate,” Agr. Biol. Chem. 37(9):2159-2165. |
Olivier et al., 1994, “Prevention of early cell death in peripheral blood lymphocytes of HIV infected individuals by an anti-oxidant: N-acetyl-cysteine,” Oxidative Stress, Cell Activation Viral Infection 323-332. |
Roederer et al., 1990, “Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine,” Proc. Natl. Acad. Sci. U.S.A. 87(12):4884-4888. |
Sells et al., 1987, “Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA,” Proc. Natl. Acad. Sci. U.S.A. 84(4):1005-1009. |
Shoji et al., 1994, “Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1) production,” Biochem. Biophys. Res. Commun. 205(1):967-975. |
Totsuka and Ohtaki, 1974, “The effects fo amino acids and metals on the infectivity of poliovirus ribonucleic acid,” Jpn. J. Microbiol. 18(2):107-112. |